Taken together, our current cross-sectional patient study demonstrated plasma concentrations of novel proinflammatory cytokine IL-36α, IL-36γ and peripheral IL-36R+ B lymphocytes were overexpressed in active SLE patients. Here, IL36A is linked to systemic lupus erythematosus.